Hacker News new | ask | show | jobs
by ineedasername 2777 days ago
Yeah, they had to make some quantity to run their trials. presumably it cost much less than $1mil/dose or they'd not have research funding at their level
1 comments

Indeed. A lot less than $1million per dose, I bet.

I understand that there are regulatory issues.

But it seems pretty clear that the standard pharma industry model doesn't work for drugs like this.